Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Biotechnology (2)
Nature Immunology (1)
Nature Medicine (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

News & Views (2)
Research (2)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Computational biology and bioinformatics
Immunology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–4 of 4 results

Advanced filters: Author: Joshua R. Veatch Clear advanced filters

Accurate somatic small variant discovery for multiple sequencing technologies with DeepSomatic

Somatic small variants in cancer genomes are identified in both short-read and long-read data.

Jimin Park
Daniel E. Cook
Kishwar Shafin
Research16 Oct 2025
Nature Biotechnology

P: 1-10
Severus detects somatic structural variation and complex rearrangements in cancer genomes using long-read sequencing

Complex structural variations and rearrangements in cancer are identified using long-read sequencing.

Ayse G. Keskus
Asher Bryant
Mikhail Kolmogorov
Research04 Apr 2025
Nature Biotechnology

P: 1-11
Tumor-infiltrating lymphocytes make inroads in non–small-cell lung cancer

A phase 1 trial shows promising anti-tumor activity of tumor-infiltrating-lymphocyte therapy in patients with advanced non–small-cell lung cancer.

Joshua R. Veatch
Sylvain Simon
Stanley R. Riddell
News & Views12 Aug 2021
Nature Medicine

Volume: 27, P: 1339-1341
Stem-cell-like CD4⁺ T cells prey on MHC class II–negative tumors

Despite the absence of MHC class II molecules on tumor cells, stem-cell-like CD4⁺ T cells specific for tumor neoantigens can mediate profound antitumor effects by licensing antigen-presenting cells and augmenting antitumor CD8⁺ T cells in the tumor microenvironment and draining lymph nodes.

Joshua R. Veatch
Stanley R. Riddell
News & Views17 Jul 2023
Nature Immunology

Volume: 24, P: 1212-1214